• SFI Discover to fund Limerick STEM engagement

    University of Limerick STEM public engagement projects are among those to benefit from Science Foundation Ireland Discover Programme funding announced by Minister for Training, Skills, Innovation, Research and Development, John Halligan TD.

    The national investment of €4.4 million has been awarded to a range of projects dedicated to educating and engaging the public in science, technology, engineering and maths (STEM).

  • SFI award to help assess the impact of research funding

    Professor Helena Lenihan from the Kemmy Businmess School has been announced as one of the first recipients of a Science Foundation Ireland award for Science Policy Research by Minister for Training, Skills, Innovation, Research and Development, John Halligan TD.

    Professor Lenihan is to receive one of the first five awards of the Science Foundation Ireland Science Policy Research Programme.

  • Minister Breen visits UL and welcomes the upcoming masters course in Artificial Intelligence

    Dr. Martin Hayes, Prof. Conor Hayes, Dr. John Nelson, Course Director Masters Artificial Intelligence, Dr Ann Ledwith, Dean of Graduate and Professional Studies, The Minister of State for Trade, Employment, Business, EU Digital Single Market and Data Protection Pat Breen (TD) Dr Mary Shire, Vice President of Research & Enterprise and Prof Edmund Magner, Dean Faculty of Science and Engineering.

  • Collaboration for Innovation: Inter-Faculty Research Collaboration Event

    This event is held in conjunction with the Research Office and Assistant Deans (International and Research).

    The aim of this event is to give you the opportunity to meet with potential collaborators from other disciplines and faculties and explore potential collaborations. By the end of the event you will have heard about others’ research areas, the inter disciplinary collaborations they are seeking, presented your area of research and had the opportunity to network with others to explore any potential interests further.

    This event is intended as an opportunity to explore potential areas of common interest – even if they are not immediately apparent.   This is for all academic and research staff, or those who support research projects.   You never know where the next opportunity will come from!   

  • EPA Research Programme Roadshow

    EPA Research will hold a series of roadshows throughout the Universities and Institutes of Technology in February and March 2018. This 2-hour workshop will be the occasion to learn more about the EPA Research Programme, in particular about the 2018 Funding Opportunities (via national & international calls). The EPA will also welcome feedback from the Research Community on its Research Programme.

    This event will be held in the Seminar Room (MSG-024) of the MSSI Building, University of Limerick.

    To register for this event please contact Martina Prendergast 

    When: Fri 23 Mar 2018, 11:00am – 1:00pm. Tea/coffee served.

  • Spin Out profile: Hooke Bio

    Dr Finola Cliffe, Dr Mark Lyons, Prof Mark Davies

    UL spin-out Hooke Bio is a new company operating in the early stages of drug discovery. Hooke Bio draws its strength from the close co-operation it has between its team of biologists and engineers. The engineers design, test and optimise new microfluidic technology: the scientists apply the technology to finding new therapeutic uses for existing drugs.

  • Research Integrity champions

    Back l-r: Christine Brennan, Research and Innovation Projects Officer; Prof. Mary O’Sullivan, Research Integrity Officer; Prof. Sheila Killian, KBS Research Integrity Champion; Dr Gabriela Avram, S&E RI Champion
    Front l-r: Dr Stephen Gallagher, EHS RI Champion; Prof. Neil Robinson, AHSS RI Champion; Dr Barry Shanahan, Research Governance Officer

  • UL Researchers Take On Global Pharma’s Biggest Challenge

    Dr Luis Padrela, Bernal Institute

    Scientists at the Bernal Institute are teaming up with Enterprise Ireland (EI) to commercialise continuous nanomanufacturing technology which promises to transform the pharmaceutical market.

    The project, which launches this month, aims to tackle the biggest challenge facing the pharmaceutical industry today. While pharmaceutical companies are continually developing new drugs, seven out of ten of those drugs never reach the patient. This is not because they are ineffective at treating disease but because they are not soluble enough to be absorbed in the body.